Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study

Schou Nørøxe, D., Flynn, A., Yde, C. W., Østrup, O., Nielsen, F. C., Skjøth-Rasmussen, J., Brennum, J., Hamerlik, P., Weischenfeldt, J., Poulsen, H. S. & Lassen, U., 20 May 2021, (E-pub ahead of print) In: Molecular Oncology.

Research output: Contribution to journal › Journal article › Research › peer-review

Immune Cell Profiling of Peripheral Blood as Signature for Response During Checkpoint Inhibition Across Cancer Types

Araujo B de Lima, V., Hansen, M., Spanggaard, I., Rohrberg, K., Reker Hadrup, S., Lassen, U. & Svane, I. M., 25 Mar 2021, In: Frontiers in Oncology. 11, p. 558248 558248.

Research output: Contribution to journal › Journal article › Research › peer-review

Phase I/IIa, open-label, multicentre study to evaluate the optimal dosing and safety of ODM-203 in patients with advanced or metastatic solid tumours

Bono, P., Massard, C., Peltola, K. J., Azaro, A., Italiano, A., Kristeleit, R. S., Curigliano, G., Lassen, U., Arkenau, H-T., Hakulinen, P., Garratt, C., Ikonen, T., Mustonen, M. V. J. & Rodon, J. A., Dec 2020, In: ESMO Open. 5, 6, p. e001081

Research output: Contribution to journal › Journal article › Research › peer-review

Phase 1 study of the immunotoxin LMB-100 in patients with mesothelioma and other solid tumors expressing mesothelin

Hassan, R., Alewine, C., Mian, I., Spreafico, A., Siu, L. L., Gomez-Roca, C., Delord, J-P., Italiano, A., Lassen, U., Soria, J-C., Bahleda, R., Thomas, A., Steinberg, S. M., Peer, C. J., Figg, W. D., Niederfellner, G., Méresse Naegelen, V. & Pastan, I., 15 Nov 2020, In: Cancer. 126, 22, p. 4936-4947 12 p.

Research output: Contribution to journal › Journal article › Research › peer-review

Larotrectinib versus Prior Therapies in Tropomyosin Receptor Kinase Fusion Cancer: An Intra-Patient Comparative Analysis

Italiano, A., Nanda, S., Briggs, A., Garcia-Foncillas, J., Lassen, U., Vassal, G., Kummar, S., van Tilburg, C. M., Hong, D. S., Laetsch, T. W., Keating, K., Reeves, J. A., Fellous, M., Childs, B. H., Drilon, A. & Hyman, D. M., 4 Nov 2020, In: Cancers. 12, 11

Research output: Contribution to journal › Journal article › Research › peer-review

Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer - Authors' reply

Subbiah, V., Lassen, U., Gasal, E., Burgess, P. & Wainberg, Z. A., Nov 2020, In: Lancet Oncology. 21, 11, p. e516

Research output: Contribution to journal › Comment/debate › Research › peer-review

Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility - a prospective, translational study

Nørøxe, D. S., Yde, C. W., Østrup, O., Michaelsen, S. R., Schmidt, A. Y., Kinalis, S., Torp, M. H., Skjøth-Rasmussen, J., Brennum, J., Hamerlik, P., Poulsen, H. S., Nielsen, F. C. & Lassen, U., Nov 2020, In: Molecular Oncology. 14, 11, p. 2727-2743 17 p.

Research output: Contribution to journal › Journal article › Research › peer-review

Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial

Subbiah, V., Lassen, U., Élez, E., Italiano, A., Curigliano, G., Javle, M., de Braud, F., Prager, G. W., Greil, R., Stein, A., Fasolo, A., Schellens, J. H. M., Wen, P. Y., Viele, K., Boran, A. D., Gasal, E., Burgess, P., Ilankumaran, P. & Wainberg, Z. A., Sep 2020, In: The Lancet Oncology. 21, 9, p. 1234-1243 10 p.

Research output: Contribution to journal › Journal article › Research › peer-review

Total burden of disease in cancer patients at diagnosis-a Danish nationwide study of multimorbidity and redeemed medication

Loeppenthin, K., Dalton, S. O., Johansen, C., Andersen, E., Christensen, M. B., Pappot, H., Petersen, L. N., Thisted, L. B., Frølich, A., Mortensen, C. E., Lassen, U., Ørsted, J. & Bidstrup, P. E., Sep 2020, In: British Journal of Cancer. 123, 6, p. 1033-1040 8 p.

Research output: Contribution to journal › Journal article › Research › peer-review

Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma

Urup, T., Gillberg, L., Kaastrup, K., Lü, M. J. S., Michaelsen, S. R., Andrée Larsen, V., Christensen, I. J., Broholm, H., Lassen, U., Grønbaek, K. & Poulsen, H. S., May 2020, In: Molecular Oncology. 14, 5, p. 964-973 10 p.

Research output: Contribution to journal › Journal article › Research › peer-review

Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcome

Araujo B de Lima, V., Borch, A., Hansen, M., Draghi, A., Spanggaard, I., Rohrberg, K., Reker Hadrup, S., Lassen, U. & Svane, I. M., Apr 2020, In: Cytotherapy. 22, 4, p. 204-213 10 p.

Research output: Contribution to journal › Journal article › Research › peer-review

Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma

Even, C., Lassen, U., Merchan, J., Le Tourneau, C., Soria, J-C., Ferte, C., Ricci, F., Diener, J. T., Yuen, E., Smith, C., Oakley, G. J., Benhadji, K. A. & Massard, C., Apr 2020, In: Investigational New Drugs. 38, 2, p. 402-409 8 p.

Research output: Contribution to journal › Journal article › Research › peer-review

Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer

Hong, D. S., Concin, N., Vergote, I., de Bono, J. S., Slomovitz, B. M., Drew, Y., Arkenau, H-T., Machiels, J-P., Spicer, J., Jones, R., Forster, M., Cornez, N., Gennigens, C., Johnson, M. L., Thistlethwaite, F. C., Rangwala, R. A., Ghatta, S., Windfeld, K., Harris, J. R., Lassen, U. N. & Coleman, R. L., 15 Mar 2020, In: Clinical Cancer Research. 26, 6, p. 1220-1228 9 p.

Research output: Contribution to journal › Journal article › Research › peer-review

Testing NTRK testing: Wet-lab and in silico comparison of RNA-based targeted sequencing assays

Pfarr, N., Kirchner, M., Lehmann, U., Leichsenring, J., Merkelbach-Bruse, S., Glade, J., Hummel, M., Stögbauer, F., Lehmann, A., Trautmann, M., Kumbrink, J., Jung, A., Dietmaier, W., Endris, V., Kazdal, D., Evert, M., Horst, D., Kreipe, H., Kirchner, T., Wardelmann, E., Lassen, U., Büttner, R., Weichert, W., Dietel, M., Schirmacher, P. & Stenzinger, A., Mar 2020, In: Genes, Chromosomes & Cancer. 59, 3, p. 178-188 11 p.

Research output: Contribution to journal › Journal article › Research › peer-review

Entrectinib for ROS1 fusion-positive NSCLC and NTRK fusion-positive solid tumours

Lassen, U., Feb 2020, In: Lancet Oncology. 21, 2, p. 193-194 2 p.

Research output: Contribution to journal › Comment/debate › Research › peer-review

Criteria for site selection in industry-sponsored clinical trials: a survey among decision-makers in biopharmaceutical companies and clinical research organizations

Dombernowsky, T., Haedersdal, M., Lassen, U. & Thomsen, S. F., 11 Dec 2019, In: Trials. 20, 1, 708.

Research output: Contribution to journal › Journal article › Research › peer-review

An open-label phase IB study to evaluate GSK3052230 in combination with paclitaxel and carboplatin, or docetaxel, in FGFR1-amplified non-small cell lung cancer

Morgensztern, D., Karaseva, N., Felip, E., Delgado, I., Burdaeva, O., Dómine, M., Lara, P., Paik, P. K., Lassen, U., Orlov, S., Trigo, J., Shomova, M., Baker-Neblett, K., Vasquez, J., Wang, X., Yan, L., Mitrica, I., DeYoung, M. P. & Garrido, P., Oct 2019, In: Lung cancer. 136, p. 74-79 6 p.

Research output: Contribution to journal › Journal article › Research › peer-review

A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer: NSGO AVANOVA1/ENGOT-OV24

Mirza, M. R., Bergmann, T. K., Mau-Sørensen, M., Christensen, R. D., Åvall-Lundqvist, E., Birrer, M. J., Jørgensen, M., Roed, H., Malander, S., Nielsen, F., Lassen, U., Brøsen, K., Bjørge, L. & Mäenpää, J., Oct 2019, In: Cancer Chemotherapy and Pharmacology. 84, 4, p. 791-798 8 p.

Research output: Contribution to journal › Journal article › Research › peer-review

Combining PARP inhibition with PD-1 inhibitors

Lassen, U., Sep 2019, In: Lancet Oncology. 20, 9, p. 1196-1198 3 p.

Research output: Contribution to journal › Journal article › Research › peer-review

Capture and Detection of Circulating Glioma Cells Using the Recombinant VAR2CSA Malaria Protein

Bang-Christensen, S. R., Pedersen, R. S., Pereira, M. A., Clausen, T. M., Løppke, C., Sand, N. T., Ahrens, T. D., Jørgensen, A. M., Lim, Y. C., Goksøyr, L., Choudhary, S., Gustavsson, T., Dagil, R., Daugaard, M., Sander, A. F., Torp, M. H., Søgaard, M., Theander, T. G., Østrup, O., Lassen, U., Hamerlik, P., Salanti, A. & Agerbæk, M. Ø., 28 Aug 2019, In: Cells. 8, 9, p. E998

Research output: Contribution to journal › Journal article › Research › peer-review

Cell-free DNA in newly diagnosed patients with glioblastoma - a clinical prospective feasibility study

Nørøxe, D. S., Østrup, O., Yde, C. W., Ahlborn, L. B., Nielsen, F. C., Michaelsen, S. R., Larsen, V. A., Skjøth-Rasmussen, J., Brennum, J., Hamerlik, P., Poulsen, H. S. & Lassen, U., 8 Jul 2019, In: Oncotarget. 10, 43, p. 4397-4406 10 p.

Research output: Contribution to journal › Journal article › Research › peer-review

Plasma total cell-free DNA is a prognostic biomarker of overall survival in metastatic solid tumour patients

Viller Tuxen, I., Barlebo Ahlborn, L., Mau-Soerensen, M., Staal Rohrberg, K., Cilius Nielsen, F., Oestrup, O., Westmose Yde, C., Richter Vogelius, I. & Lassen, U., Jul 2019, In: British Journal of Cancer. 121, 2, p. 125-130 6 p.

Research output: Contribution to journal › Journal article › Research › peer-review

Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trial

de Bono, J. S., Concin, N., Hong, D. S., Thistlethwaite, F. C., Machiels, J-P., Arkenau, H-T., Plummer, R., Jones, R. H., Nielsen, D., Windfeld, K., Ghatta, S., Slomovitz, B. M., Spicer, J. F., Yachnin, J., Ang, J. E., Mau-Sørensen, P. M., Forster, M. D., Collins, D., Dean, E., Rangwala, R. A. & Lassen, U., Mar 2019, In: Lancet Oncology. 20, 3, p. 383-393 11 p.

Research output: Contribution to journal › Journal article › Research › peer-review

Application of cell-free DNA for genomic tumor profiling: a feasibility study

Ahlborn, L. B., Rohrberg, K. S., Gabrielaite, M., Tuxen, I. V., Yde, C. W., Spanggaard, I., Santoni-Rugiu, E., Nielsen, F. C., Lassen, U., Mau-Sorensen, M. & Østrup, O., 15 Feb 2019, In: Oncotarget. 10, 14, p. 1388-1398 11 p.

Research output: Contribution to journal › Journal article › Research › peer-review

Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma

Hilf, N., Kuttruff-Coqui, S., Frenzel, K., Bukur, V., Stevanović, S., Gouttefangeas, C., Platten, M., Tabatabai, G., Dutoit, V., van der Burg, S. H., Straten, P. T., Martinez-Ricarte, F., Ponsati, B., Okada, H., Lassen, U., Admon, A., Ottensmeier, C. H., Ulges, A., Kreiter, S., von Deimling, A., Skardelly, M., Migliorini, D., Kroep, J. R., Idorn, M., Rodon, J., Piro, J., Poulsen, H. S., Shraibman, B., McCann, K., Mendrzyk, R., Lower, M., Stieglbauer, M., Britten, C. M., Capper, D., Welters, M. J. P., Sahuquillo, J., Kiesel, K., Derhovanessian, E., Rusch, E., Bunse, L., Song, C., Heesch, S., Wagner, C., Kemmer-Bruck, A., Ludwig, J., Castle, J. C., Schoor, O., Tadmor, A. D., Green, E., Fritsche, J., Meyer, M., Pawlowski, N., Dorner, S., Hoffgaard, F., Rossler, B., Maurer, D., Weinschenk, T., Reinhardt, C., Huber, C., Rammensee, H-G., Singh-Jasuja, H., Sahin, U., Dietrich, P-Y. & Wick, W., Feb 2019, In: Nature. 566, 7745, p. E13

Research output: Contribution to journal › Journal article › Research

Actively personalized vaccination trial for newly diagnosed glioblastoma

Hilf, N., Kuttruff-Coqui, S., Frenzel, K., Bukur, V., Stevanović, S., Gouttefangeas, C., Platten, M., Tabatabai, G., Dutoit, V., van der Burg, S. H., Thor Straten, P., Martínez-Ricarte, F., Ponsati, B., Okada, H., Lassen, U., Admon, A., Ottensmeier, C. H., Ulges, A., Kreiter, S., von Deimling, A., Skardelly, M., Migliorini, D., Kroep, J. R., Idorn, M., Rodon, J., Piró, J., Poulsen, H. S., Shraibman, B., McCann, K., Mendrzyk, R., Löwer, M., Stieglbauer, M., Britten, C. M., Capper, D., Welters, M. J. P., Sahuquillo, J., Kiesel, K., Derhovanessian, E., Rusch, E., Bunse, L., Song, C., Heesch, S., Wagner, C., Kemmer-Brück, A., Ludwig, J., Castle, J. C., Schoor, O., Tadmor, A. D., Green, E., Fritsche, J., Meyer, M., Pawlowski, N., Dorner, S., Hoffgaard, F., Rössler, B., Maurer, D., Weinschenk, T., Reinhardt, C., Huber, C., Rammensee, H-G., Singh-Jasuja, H., Sahin, U., Dietrich, P-Y. & Wick, W., 10 Jan 2019, In: Nature. 565, 7738, p. 240-245 6 p.

Research output: Contribution to journal › Letter › Research › peer-review

Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma

Shraibman, B., Barnea, E., Kadosh, D. M., Haimovich, Y., Slobodin, G., Rosner, I., López-Larrea, C., Hilf, N., Kuttruff, S., Song, C., Britten, C., Castle, J., Kreiter, S., Frenzel, K., Tatagiba, M., Tabatabai, G., Dietrich, P-Y., Dutoit, V., Wick, W., Platten, M., Winkler, F., von Deimling, A., Kroep, J., Sahuquillo, J., Martinez-Ricarte, F., Rodon, J., Lassen, U., Ottensmeier, C., van der Burg, S. H., Thor Straten, P., Poulsen, H. S., Ponsati, B., Okada, H., Rammensee, H-G., Sahin, U., Singh, H. & Admon, A., 1 Jan 2019, In: Molecular & cellular proteomics : MCP. 18, 6, p. 1255-1268 14 p.

Research output: Contribution to journal › Journal article › Research › peer-review

A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancer

Cejalvo, J-M., Jacob, W., Fleitas Kanonnikoff, T., Felip, E., Navarro Mendivil, A., Martinez Garcia, M., Taus Garcia, A., Leighl, N., Lassen, U., Mau-Soerensen, M., Adessi, C., Michielin, F., James, I., Ceppi, M., Hasmann, M., Weisser, M. & Cervantes, A., 2019, In: ESMO Open. 4, 4, p. e000532

Research output: Contribution to journal › Journal article › Research › peer-review

Copenhagen Prospective Personalized Oncology (CoPPO) - Clinical utility of using molecular profiling to select patients to phase 1 trials

Tuxen, I. V., Rohrberg, K. S., Østrup, O., Ahlborn, L. B., Schmidt, A. Y., Spanggaard, I., Hasselby, J. P., Santoni-Rugiu, E., Yde, C. W., Mau-Soerensen, M., Nielsen, F. C. & Lassen, U., 2019, In: Clinical Cancer Research. 25, 4, p. 1239-1247 9 p.

Research output: Contribution to journal › Journal article › Research › peer-review

Extracranial metastases in glioblastoma-Two case stories

Schou Nørøxe, D., Regner Michaelsen, S., Broholm, H., Møller, S., Skovgaard Poulsen, H. & Lassen, U., 2019, In: Clinical Case Reports. 7, 2, p. 289-294 6 p.

Research output: Contribution to journal › Journal article › Research › peer-review

High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancer

Bertelsen, B., Tuxen, I. V., Yde, C. W., Gabrielaite, M., Torp, M. H., Kinalis, S., Oestrup, O., Rohrberg, K., Spangaard, I., Santoni-Rugiu, E., Wadt, K., Mau-Sorensen, M., Lassen, U. & Nielsen, F. C., 2019, In: Genome Medicine. 4, 1, p. 13 13.

Research output: Contribution to journal › Journal article › Research › peer-review

How I treat NTRK gene fusion-positive cancers

Lassen, U., 2019, In: ESMO Open. 4, Suppl 2, p. e000612

Research output: Contribution to journal › Review › Research › peer-review

Socioeconomic Differences in Referral to Phase I Cancer Clinical Trials: A Danish Matched Cancer Case-Control Study

Gad, K. T., Johansen, C., Duun-Henriksen, A. K., Krøyer, A., Olsen, M. H., Lassen, U., Mau-Sørensen, M. & Oksberg Dalton, S., 2019, In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 13, p. 1111-1119

Research output: Contribution to journal › Journal article › Research › peer-review

Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer

Schneeweiss, A., Park-Simon, T-W., Albanell, J., Lassen, U., Cortés, J., Dieras, V., May, M., Schindler, C., Marmé, F., Cejalvo, J. M., Martinez-Garcia, M., Gonzalez, I., Lopez-Martin, J., Welt, A., Levy, C., Joly, F., Michielin, F., Jacob, W., Adessi, C., Moisan, A., Meneses-Lorente, G., Racek, T., James, I., Ceppi, M., Hasmann, M., Weisser, M. & Cervantes, A., Oct 2018, In: Investigational New Drugs. 36, 5, p. 848-859 12 p.

Research output: Contribution to journal › Journal article › Research › peer-review

Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated non-melanoma solid tumors

Ahlborn, L. B., Tuxen, I. V., Mouliere, F., Kinalis, S., Schmidt, A. Y., Rohrberg, K. S., Santoni-Rugiu, E., Nielsen, F. C., Lassen, U., Yde, C. W., Oestrup, O. & Mau-Sorensen, M., 24 Aug 2018, In: Oncotarget. 9, 66, p. 32570-32579 10 p.

Research output: Contribution to journal › Journal article › Research › peer-review

Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival

Michaelsen, S. R., Urup, T., Olsen, L. R., Broholm, H., Lassen, U. & Poulsen, H. S., May 2018, In: Journal of Neuro-Oncology. 137, 3, p. 533-542 10 p.

Research output: Contribution to journal › Journal article › Research › peer-review

Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children

Drilon, A., Laetsch, T. W., Kummar, S., DuBois, S. G., Lassen, U. N., Demetri, G. D., Nathenson, M., Doebele, R. C., Farago, A. F., Pappo, A. S., Turpin, B., Dowlati, A., Brose, M. S., Mascarenhas, L., Federman, N., Berlin, J., El-Deiry, W. S., Baik, C., Deeken, J., Boni, V., Nagasubramanian, R., Taylor, M., Rudzinski, E. R., Meric-Bernstam, F., Sohal, D. P. S., Ma, P. C., Raez, L. E., Hechtman, J. F., Benayed, R., Ladanyi, M., Tuch, B. B., Ebata, K., Cruickshank, S., Ku, N. C., Cox, M. C., Hawkins, D. S., Hong, D. S. & Hyman, D. M., 22 Feb 2018, In: The New England journal of medicine. 378, 8, p. 731-739 9 p.

Research output: Contribution to journal › Journal article › Research › peer-review

A drug-drug interaction study to assess the effect of the CYP1A2 inhibitor fluvoxamine on the pharmacokinetics of dovitinib (TKI258) in patients with advanced solid tumors

de Weger, V. A., Goel, S., von Moos, R., Schellens, J. H. M., Mach, N., Tan, E., Anand, S., Scott, J. W. & Lassen, U., 2018, In: Cancer Chemotherapy and Pharmacology. 81, 1, p. 73-80

Research output: Contribution to journal › Journal article › Research › peer-review

A systematic review of targeted agents for non-small cell lung cancer

Vestergaard, H. H., Christensen, M. R. & Lassen, U. N., 2018, In: Acta oncologica . 57, 2, p. 176-186

Research output: Contribution to journal › Journal article › Research › peer-review

Biomarkers in Recurrent Grade III Glioma Patients Treated with Bevacizumab and Irinotecan

Toft, A., Urup, T., Christensen, I. J., Michaelsen, S. R., Lukram, B., Grunnet, K., Larsen, V. A., Lassen, U., Broholm, H. & Poulsen, H. S., 2018, In: Cancer Investigation. 36, 2, p. 165-174

Research output: Contribution to journal › Journal article › Research › peer-review

First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer

Massard, C., Azaro, A., Soria, J-C., Lassen, U., Le Tourneau, C., Sarker, D., Smith, C., Ohnmacht, U., Oakley, G., Patel, B. K. R., Yuen, E. S. M., Benhadji, K. A. & Rodon, J., 2018, In: Annals of Oncology. 29, 9, p. 1911-1917 7 p.

Research output: Contribution to journal › Journal article › Research › peer-review

Outcome of Bevacizumab Therapy in Patients with Recurrent Glioblastoma Treated with Angiotensin System Inhibitors

Johansen, M. D., Urup, T., Holst, C. B., Christensen, I. J., Grunnet, K., Lassen, U., Friis, S. & Poulsen, H. S., 2018, In: Cancer Investigation. 36, 9-10, p. 512-519 8 p.

Research output: Contribution to journal › Journal article › Research › peer-review

Patient information in phase I trials: A systematic review

Gad, K. T., Lassen, U., Mau-Sørensen, M., Høybye, M. T. & Johansen, C., 2018, In: Psycho-Oncology. 27, 3, p. 768-780

Research output: Contribution to journal › Journal article › Research › peer-review

TRK Inhibition: A New Tumor-Agnostic Treatment Strategy

Kummar, S. & Lassen, U. N., 2018, In: Targeted Oncology. 13, 5, p. 545-556 12 p.

Research output: Contribution to journal › Journal article › Research › peer-review

VEGF-C Sustains VEGFR2 Activation under Bevacizumab Therapy and Promotes Glioblastoma Maintenance

Michaelsen, S. R., Staberg, M., Pedersen, H., Jensen, K. E., Majewski, W., Broholm, H., Nedergaard, M. K., Meulengracht, C., Urup, T., Villingshøj, M., Lukacova, S., Skjøth-Rasmussen, J., Brennum, J., Kjær, A., Lassen, U., Stockhausen, M-T., Poulsen, H. S. & Hamerlik, P., 2018, In: Neuro-Oncology. 20, 11, p. 1462-74

Research output: Contribution to journal › Journal article › Research › peer-review

Concordance of Mutation Detection in Circulating Tumor DNA in Early Clinical Trials Using Different Blood Collection Protocols

Ahlborn, L. B., Madsen, M., Jonson, L., Nielsen, F. C., Lassen, U., Yde, C. W. & Mau-Sorensen, M., 1 Oct 2017, In: Clinical Laboratory. 63, 10, p. 1755-1759 5 p.

Research output: Contribution to journal › Journal article › Research › peer-review